Author: Glenda M. Bishop Stephen R. Robinson
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.21, Iss.10, 2004-01, pp. : 621-630
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease
Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. :
Apolipoprotein E and Alzheimers Disease: Therapeutic Implications
By Higuchi M.
CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. :
The Glutamatergic System and Alzheimers Disease: Therapeutic Implications
By Butterfield D.A. Pocernich C.B.
CNS Drugs, Vol. 17, Iss. 9, 2003-01 ,pp. :
Metrifonate: A Review of its Use in Alzheimers Disease
CNS Drugs, Vol. 13, Iss. 6, 2000-06 ,pp. :